Paul Averback

CA·SEDI

Nymox Pharmaceutical Corporation

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 01 Feb 2017 for Nymox Pharmaceutical Corporation.

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Paul Averback: trading record in brief

Our data holds just one disclosure by Paul Averback, dated 1 February 2017, reporting a share grant in Nymox Pharmaceutical Corporation. Further filings will be added here. Source: insider filings from SEDI. Past trades are no guide to future returns.

Companies and markets linked to Paul Averback

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Nymox Pharmaceutical Corporation (CA)

Declarations1 total

◆

Paul Averback

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives23 Nov 2015Nymox Pharmaceutical Corporation

0SEDI

4,250,000 sharesCommon SharesTSXSEDI:2950879

1 of 1 declaration

Paul Averback

Insider track record

Paul Averback: trading record in brief

Companies and markets linked to Paul Averback

Related entities

Paul Averback

Insider track record

Paul Averback: trading record in brief

Companies and markets linked to Paul Averback

Related entities